Skip to main content
Log in

Construction, Purification, and Characterization of Anti-BAFF scFv–Fc Fusion Antibody Expressed in CHO/dhfr Cells

  • Published:
Applied Biochemistry and Biotechnology Aims and scope Submit manuscript

Abstract

Elevated levels of B-cell-activating factor of the tumor necrosis factor family (BAFF) have been implicated in the pathogenesis of autoimmune diseases in human. In this study, we have constructed a vector for the expression of a novel compact antibody composed of anti-BAFF single-chain antibody fragment (scFv) and the Fc region (the hinge region, CH2, and CH3 domains) of human IgG1 in Chinese hamster ovary cells. The scFv–Fc fusion protein, showing spontaneous Fc fragment-mediated homodimerization via disulfide bridges, was affinity-purified on protein A Sepharose from culture supernatant. The scFv–Fc antibody was demonstrated to retain high binding affinity to antigen and prolonged clearance time in blood and to possess some human IgG crystallizable fragment effector functions such as protein A binding and antibody-dependent cellular cytotoxicity. These results suggest that this recombinant antibody may have therapeutic applications in the therapy of autoimmune disorders mediated by BAFF.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7
Fig. 8

Similar content being viewed by others

Abbreviations

BLyS:

B lymphocyte stimulator

BAFF:

B-cell activating factor belonging to the TNF family

BSA:

Bovine serum albumin

FBS:

Fetal bovine serum

Ab:

Antibody

TALL-1:

TNF- and ApoL-related leukocyte-expressed ligand 1

THANK:

TNF homologue that activates apoptosis, nuclear factor-kB, and c-Jun NH2 terminal kinase

TNF:

Tumor necrosis factor

Fc:

Crystallizing fragment, consists of CH2 and CH3, glycosylation site, not antigen binding, but responsible for effector functions

G418:

Neomycin

VH:

Immunoglobulin heavy-chain variable region

VL:

Immunoglobulin light-chain variable region

CH2 and CH3:

Immunoglobulin heavy-chain constant regions 2 and 3

HRP:

Horseradish peroxidase

mAb:

Monoclonal antibody

TBST:

Tris-buffered saline Tween-20

References

  1. Schneider, P., Mackay, F., Steiner, V., Hofmann, K., Bodmer, J. L., Holler, N., et al. (1999). The Journal of Experimental Medicine, 189, 1747–1756. doi:10.1084/jem.189.11.1747.

    Article  CAS  Google Scholar 

  2. Shu, H. B., Hu, W. H., & Johnson, H. (1999). Journal of Leukocyte Biology, 65, 680–683.

    CAS  Google Scholar 

  3. Mukhopadhyay, A., Ni, J., Zhai, Y., Yu, G. L., & Aggarwal, B. B. (1999). The Journal of Biological Chemistry, 274, 15978–15981. doi:10.1074/jbc.274.23.15978.

    Article  CAS  Google Scholar 

  4. Moore, P. A., Belvedere, O., Orr, A., Pieri, K., LaFleur, D. W., Feng, P., et al. (1999). Science, 285, 260–263. doi:10.1126/science.285.5425.260.

    Article  CAS  Google Scholar 

  5. Tribouley, C., Wallroth, M., Chan, V., Paliard, X., Fang, E., Lamson, G., et al. (1999). The Journal of Biological Chemistry, 380, 1443–1447. doi:10.1515/BC.1999.186.

    Article  CAS  Google Scholar 

  6. Melchers, F. (2003). Annals of the Rheumatic Diseases, 62, 225–227. doi:10.1136/ard.62.suppl_2.ii25.

    Article  Google Scholar 

  7. Schneider, P., & Tschopp, J. (2003). Immunology Letters, 88, 57–62. doi:10.1016/S0165-2478(03)00050-6.

    Article  CAS  Google Scholar 

  8. Mackay, J. F., & Browning, L. (2002). Nature Reviews. Immunology, 2, 465–475. doi:10.1038/nri844.

    Article  CAS  Google Scholar 

  9. Schiemann, B., Gommerman, J. L., Vora, K., Cachero, T. G., Shulgamorskaya, S., Dobles, M., et al. (2001). Science, 293, 2111–2114. doi:10.1126/science.1061964.

    Article  CAS  Google Scholar 

  10. Ramanujam, M., & Davidson, A. (2004). Arthritis Research & Therapy, 6, 197–202. doi:10.1186/ar1222.

    Article  CAS  Google Scholar 

  11. Cao, P., Xia, Z., Song, W., & Zhang, S. (2005). Immunology Letters, 101, 87–94. doi:10.1016/j.imlet.2005.05.001.

    Article  CAS  Google Scholar 

  12. Adams, G. P., Schier, R., Marshall, K., Wolf, E. J., McCall, A. M., Marks, J. D., et al. (1998). Cancer Research, 58, 485–490.

    CAS  Google Scholar 

  13. Persic, L., Roberts, A., Wilton, J., Cattaneo, A., Bradbury, A., & Hoogenboom, H. R. (1997). Gene, 187, 9–18. doi:10.1016/S0378-1119(96)00628-2.

    Article  CAS  Google Scholar 

  14. Powers, D. B., Amersdorfer, P., Poul, M. A., Nielsen, U. B., Shalaby, M. R., Adams, G. P., et al. (2001). Journal of Immunological Methods, 251, 123–135. doi:10.1016/S0022-1759(00)00290-8.

    Article  CAS  Google Scholar 

  15. Kaufman, R. J., Wasley, L. C., Spiliotes, A. J., Gossels, S. D., Latt, S. A., Larsen, G. R., et al. (1985). Molecular and Cellular Biology, 5, 1750–1759.

    CAS  Google Scholar 

  16. Kim, S. J., Kim, N. S., Ryu, C. J., Hong, H. J., & Lee, G. M. (1998). Biotechnology and Bioengineering, 58, 73–84. doi:10.1002/(SICI)1097-0290(19980405)58:1<73::AID-BIT8>3.0.CO;2-R.

    Article  CAS  Google Scholar 

  17. Wurm, F. M., Pallavicini, M. G., & Arathoon, R. (1992). Developments in Biological Standardization, 76, 69–82.

    CAS  Google Scholar 

  18. Omasa, T. (2002). Journal of Bioscience and Bioengineering, 94(6), 600–605.

    CAS  Google Scholar 

  19. Yoshikawa, T., Nakanishi, F., Ogura, Y., Oi, D., Omasa, T., Katakura, Y., et al. (2000). Biotechnology Progress, 16(5), 710–715. doi:10.1021/bp000114e.

    Article  CAS  Google Scholar 

  20. Pelletier, M. R., Hatada, E. N., Scholz, G., & Scheidereit, C. (1997). Nucleic Acids Research, 25, 3995–4003. doi:10.1093/nar/25.20.3995.

    Article  CAS  Google Scholar 

  21. Cao, P., Mei, J. J., Diao, Z. Y., & Zhang, S. Q. (2005). Protein Expression and Purification, 41, 199–206. doi:10.1016/j.pep.2005.01.001.

    Article  CAS  Google Scholar 

  22. Nardelli, B., Belvedere, O., Roschke, V., Moore, P. A., Olsen, H. S., Migone, T. S., et al. (2001). Blood, 97, 198–204. doi:10.1182/blood.V97.1.198.

    Article  CAS  Google Scholar 

  23. Cao, P., Tang, X. M., Guan, Z. B., Diao, Z. Y., & Zhang, S. Q. (2005). Protein Expression and Purification, 43, 157–164. doi:10.1016/j.pep.2005.04.022.

    Article  CAS  Google Scholar 

  24. Friguet, B., Chaffotte, A. F., Djavadi-Ohaniance, L., & Goldberg, M. E. (1985). Journal of Immunological Methods, 77, 305–319. doi:10.1016/0022-1759(85)90044-4.

    Article  CAS  Google Scholar 

  25. Ono, K., Kamihira, M., Kuga, Y., Matsumoto, H., Hotta, A., Itoh, T., et al. (2003). Journal of Bioscience and Bioengineering, 95, 231–238.

    CAS  Google Scholar 

  26. Huston, J. S., George, A. J. T., Adams, G. P., Stafford, W. F., Jamar, F., Tai, M., et al. (1996). The Quarterly Journal of Nuclear Medicine, 40, 320–333.

    CAS  Google Scholar 

  27. Yokota, T., Milenic, D. E., Whitlow, M., & Schlom, J. (1992). Cancer Research, 52, 3402–3408.

    CAS  Google Scholar 

  28. Reff, M. E., & Heard, C. (2001). Critical Reviews in Oncology/Hematology, 40, 25–35. doi:10.1016/S1040-8428(01)00132-9.

    Article  CAS  Google Scholar 

  29. Cao, P., Zhang, S., Gong, Z., Tang, X., Cao, M., & Hu, Y. (2006). Applied Microbiology and Biotechnology, 73, 151–157. doi:10.1007/s00253-006-0432-4.

    Article  CAS  Google Scholar 

  30. Jefferis, R. (2005). Biotechnology Progress, 21, 11–16. doi:10.1021/bp040016j.

    Article  CAS  Google Scholar 

  31. Xiong, K. H., Liang, Q. C., Xiong, H., Zou, C. X., Gao, G. D., Zhao, Z. W., et al. (2005). Biotechnology Letters, 27, 1713–1717. doi:10.1007/s10529-005-2736-3.

    Article  CAS  Google Scholar 

  32. Strutzenberger, K., Borth, N., Kunert, R., Steinfellner, W., & Katinger, H. (1999). Journal of Biotechnology, 69, 215–226. doi:10.1016/S0168-1656(99)00044-9.

    Article  CAS  Google Scholar 

  33. Kim, S. J., & Lee, G. M. (1999). Biotechnology and Bioengineering, 64, 741–749. doi:10.1002/(SICI)1097-0290(19990920)64:6<741::AID-BIT14>3.0.CO;2-X.

    Article  CAS  Google Scholar 

  34. Baker, K. P., Edwards, B. M., Main, S. H., Choi, G. H., Wager, R. E., Halpern, W. G., et al. (2003). Arthritis and Rheumatism, 48, 3253–3265. doi:10.1002/art.11299.

    Article  CAS  Google Scholar 

  35. Cartron, G., Dacheux, L., Salles, G., Solal-Celigny, P., Bardos, P., Colombat, P., et al. (2002). Blood, 99, 754–758. doi:10.1182/blood.V99.3.754.

    Article  CAS  Google Scholar 

Download references

Acknowledgments

This work was supported by grants of the Nanjing Normal University and Jiangsu Province Graduate Innovation Project (No. 1612005024) and the International Cooperation of Jiangsu Province (No. BZ2007078). We are particularly grateful to Dr Ling Wang in Nanjing Medical University for help and technical support in the experiments of Flow Cytometry Analysis.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shuangquan Zhang.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cao, M., Cao, P., Yan, H. et al. Construction, Purification, and Characterization of Anti-BAFF scFv–Fc Fusion Antibody Expressed in CHO/dhfr Cells. Appl Biochem Biotechnol 157, 562–574 (2009). https://doi.org/10.1007/s12010-008-8434-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12010-008-8434-6

Keywords

Navigation